Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Tonix Pharmaceuticals Holding (TNXP) EBT Margin (2023 - 2025)

Tonix Pharmaceuticals Holding (TNXP) has 3 years of EBT Margin data on record, last reported at 967.66% in Q3 2025.

  • For Q3 2025, EBT Margin fell 41649.0% year-over-year to 967.66%; the TTM value through Sep 2025 reached 958.02%, up 92629.0%, while the annual FY2024 figure was 1354.28%, 111672.0% down from the prior year.
  • EBT Margin reached 967.66% in Q3 2025 per TNXP's latest filing, up from 1416.22% in the prior quarter.
  • Across five years, EBT Margin topped out at 551.17% in Q3 2024 and bottomed at 3501.59% in Q2 2024.
  • Average EBT Margin over 3 years is 1149.79%, with a median of 860.23% recorded in 2024.
  • Peak YoY movement for EBT Margin: tumbled -268324bps in 2024, then surged 208537bps in 2025.
  • A 3-year view of EBT Margin shows it stood at 701.3% in 2023, then decreased by -24bps to 870.64% in 2024, then decreased by -11bps to 967.66% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 967.66% in Q3 2025, 1416.22% in Q2 2025, and 660.93% in Q1 2025.